Studies related to Symptoms of Myotonia and Cannabis

A Role For Cannabinoids In The Treatment Of Myotonia? Report Of Compassionate Use In A Small Cohort Of Patients

Effect Decrease
Trial Design Non-controlled trial
Trial Length 2-4 Weeks
Number of Subjects 6
Sex Both Genders
Notes for this study:
Patients with myotonia took THC/CBD oil (10.29 mg CBD and 1.10 mg of THC twice daily) for 2 weeks and adjusted to a dose of 20.58 mg CBD and 3.31 mg THC twice per day for another 4 weeks. All participants saw improvements in myotonia behavior, hand-opening time, and myalgia.
Funding issues for this study:
"Hubertus Apotheke Berlin was supported by an unrestricted
grant of Nexien Biopharma, Inc., for the preparation of the CBD/THC
oil."